Please login to the form below

Not currently logged in
Email:
Password:

EUnetHTA

This page shows the latest EUnetHTA news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 4 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Taking a strategic approach Taking a strategic approach

    Whether the European Network of Health Technology Assessment (EUnetHTA) - set up to create an effective and sustainable network for HTA across Europe - could fulfil this role remains to be seen. ... Nonetheless, EUnetHTA has been collaborating with the

  • EU gives boost to its network of HTA bodies EU gives boost to its network of HTA bodies

    Aims of EUnetHTA:. Supporting efficient production and use of HTA in countries across Europe. ... Main functions of EUnetHTA are to: . Be a contact point for the HTA community in Europe .

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    recent plan by the Agency and the HTA body EUnetHTA to work together on making sure that data required by the EMA in its regulatory process aligns with market access requirements

  • NICE’s International Footprint NICE’s International Footprint

    In Europe this takes the form of EUnetHTA, of which NICE itself is a member.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics